pubmed-article:15298504 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0043227 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0042071 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0264995 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0034037 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0205100 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C1704324 | lld:lifeskim |
pubmed-article:15298504 | lifeskim:mentions | umls-concept:C1880156 | lld:lifeskim |
pubmed-article:15298504 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15298504 | pubmed:dateCreated | 2004-8-9 | lld:pubmed |
pubmed-article:15298504 | pubmed:abstractText | To report a comprehensive literature review focused on comparing the risk of complications with urokinase versus recombinant tissue plasminogen activator (rtPA) for thrombolytic treatment of peripheral arterial occlusions. | lld:pubmed |
pubmed-article:15298504 | pubmed:language | eng | lld:pubmed |
pubmed-article:15298504 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15298504 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15298504 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15298504 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15298504 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15298504 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15298504 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15298504 | pubmed:issn | 1526-6028 | lld:pubmed |
pubmed-article:15298504 | pubmed:author | pubmed-author:OurielKenneth... | lld:pubmed |
pubmed-article:15298504 | pubmed:author | pubmed-author:KandarpaKrish... | lld:pubmed |
pubmed-article:15298504 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15298504 | pubmed:volume | 11 | lld:pubmed |
pubmed-article:15298504 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15298504 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15298504 | pubmed:pagination | 436-46 | lld:pubmed |
pubmed-article:15298504 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:meshHeading | pubmed-meshheading:15298504... | lld:pubmed |
pubmed-article:15298504 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15298504 | pubmed:articleTitle | Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work. | lld:pubmed |
pubmed-article:15298504 | pubmed:affiliation | Department of Vascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ourielk@ccf.org | lld:pubmed |
pubmed-article:15298504 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15298504 | pubmed:publicationType | Review | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15298504 | lld:pubmed |